Filing Details
- Accession Number:
- 0001209191-22-000122
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-03 16:03:24
- Reporting Period:
- 2021-12-30
- Accepted Time:
- 2022-01-03 16:03:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1831097 | Agilon Health Inc. | AGL | Services-Misc Health & Allied Services, Nec (8090) | 371915147 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1855972 | Theodore Halkias | C/O Agilon Health, Inc. 1 World Trade Center, Suite 2000 Long Beach CA 90831 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-30 | 12,113 | $1.00 | 17,547 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-30 | 12,113 | $27.54 | 5,434 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-12-31 | 1,162 | $1.00 | 6,596 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-31 | 1,162 | $27.55 | 5,434 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options (Rights to Buy) | Disposition | 2021-12-30 | 12,113 | $0.00 | 12,113 | $1.00 |
Common Stock | Options (Rights to Buy) | Disposition | 2021-12-31 | 1,162 | $0.00 | 1,162 | $1.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,702,609 | 2027-04-27 | No | 4 | M | Direct | |
1,701,447 | 2027-04-27 | No | 4 | M | Direct |
Footnotes
- Includes restricted stock units.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021.